Total Payments
$968.19
2023 Payments
$80.45
Companies
13
Transactions
35
Medicare Patients
1,339
Medicare Billing
$109,746

Payment Breakdown by Category

Food & Beverage$968.19 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $968.19 35 100.0%

Top Paying Companies

Company Total Records Latest Year
Novartis Pharmaceuticals Corporation $188.44 11 $0 (2023)
Amgen Inc. $160.31 5 $0 (2023)
Alnylam Pharmaceuticals Inc. $125.00 1 $0 (2021)
ABIOMED $106.47 1 $0 (2022)
Bayer HealthCare Pharmaceuticals Inc. $104.38 2 $0 (2022)
PFIZER INC. $81.11 4 $0 (2022)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $48.48 3 $0 (2022)
Merck Sharp & Dohme LLC $34.41 2 $0 (2022)
Janssen Pharmaceuticals, Inc $34.40 1 $0 (2022)
E.R. Squibb & Sons, L.L.C. $31.48 2 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2023 $80.45 5 Novartis Pharmaceuticals Corporation ($39.36)
2022 $505.19 19 Novartis Pharmaceuticals Corporation ($149.08)
2021 $382.55 11 Alnylam Pharmaceuticals Inc. ($125.00)

All Payment Transactions

35 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
10/31/2023 Abbott Laboratories DIAMONDBACK CORONARY (Device) Food and Beverage In-kind items and services $22.99 General
Category: Vascular
07/26/2023 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $13.01 General
Category: Cardiology/Vascular Diseases
03/21/2023 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $13.02 General
Category: Cardiology/Vascular Diseases
02/21/2023 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $13.33 General
Category: Cardiology/Vascular Diseases
01/24/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $18.10 General
Category: Cardiology
12/13/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $13.84 General
Category: CARDIOVASCULAR
11/10/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $20.47 General
Category: CARDIOVASCULAR
10/19/2022 ABIOMED Impella (Device) Food and Beverage In-kind items and services $106.47 General
Category: Cardiology/Vascular Diseases
10/11/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $15.70 General
Category: CARDIOVASCULAR
09/21/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $77.71 General
Category: Cardio-renal
09/15/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $18.60 General
Category: CARDIOVASCULAR
09/14/2022 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $16.93 General
Category: Electromedical and Electrotherapeutic Apparatus
08/18/2022 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $17.24 General
Category: Cardiology
08/16/2022 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $18.60 General
Category: CARDIOVASCULAR
08/09/2022 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $16.26 General
Category: Cardiology
08/03/2022 Bayer HealthCare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $26.67 General
Category: Cardio-renal
07/28/2022 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $14.73 General
Category: Cardiology
07/14/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $20.23 General
Category: CARDIOVASCULAR
07/11/2022 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $16.88 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/23/2022 Merck Sharp & Dohme LLC VERQUVO (Drug) Food and Beverage In-kind items and services $13.83 General
Category: CARDIOVASCULAR
05/19/2022 E.R. Squibb & Sons, L.L.C. ELIQUIS (Drug) Food and Beverage Cash or cash equivalent $14.99 General
Category: Cardiovascular
04/20/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $18.39 General
Category: CARDIOVASCULAR
04/03/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $34.40 General
Category: Cardiovascular & Metabolism
01/18/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $23.25 General
Category: CARDIOVASCULAR
07/26/2021 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) LifeVest (Device) Food and Beverage Cash or cash equivalent $17.95 General
Category: Electromedical and Electrotherapeutic Apparatus

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 7 426 510 $87,855 $37,878
2021 8 543 666 $99,975 $45,273
2020 6 370 445 $63,260 $26,595
Total Patients
1,339
Total Services
1,621
Medicare Billing
$109,746
Procedure Codes
22

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 192 220 $38,500 $17,396 45.2%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 81 119 $18,445 $7,921 42.9%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 35 35 $11,200 $4,598 41.1%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 60 78 $8,580 $3,617 42.2%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 19 19 $5,225 $2,019 38.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 19 19 $3,705 $1,271 34.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 20 20 $2,200 $1,055 48.0%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 200 228 $39,900 $19,258 48.3%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2021 97 159 $17,490 $7,581 43.3%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2021 67 92 $14,260 $6,305 44.2%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 108 111 $12,210 $5,672 46.4%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2021 22 23 $7,360 $3,055 41.5%
99204 New patient outpatient visit, total time 45-59 minutes Office 2021 16 16 $4,400 $1,792 40.7%
99203 New patient outpatient visit, total time 30-44 minutes Office 2021 15 15 $2,925 $1,049 35.9%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2021 18 22 $1,430 $561.00 39.2%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 113 163 $17,930 $7,818 43.6%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 88 110 $17,050 $7,464 43.8%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 31 31 $9,920 $4,176 42.1%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 63 63 $6,930 $3,142 45.3%
99203 New patient office or other outpatient visit, typically 30 minutes Office 2020 42 42 $8,190 $2,924 35.7%
99213 Established patient office or other outpatient visit, typically 15 minutes Facility 2020 19 20 $2,200 $678.36 30.8%
99231 Subsequent hospital inpatient care, typically 15 minutes per day Facility 2020 14 16 $1,040 $392.06 37.7%

About Saba Ilyas

Saba Ilyas is a Student in an Organized Health Care Education/Training Program healthcare provider based in Utica, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/15/2019. The National Provider Identifier (NPI) number assigned to this provider is 1043784895.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Saba Ilyas has received a total of $968.19 in payments from pharmaceutical and medical device companies, with $80.45 received in 2023. These payments were reported across 35 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($968.19).

As a Medicare-enrolled provider, Ilyas has provided services to 1,339 Medicare beneficiaries, totaling 1,621 services with total Medicare billing of $109,746. Data is available for 3 years (2020–2022), covering 22 distinct procedure/service records.

Practice Information

Products in Payments

  • Repatha (Biological) $160.31
  • ENTRESTO (Drug) $156.83
  • ONPATTRO (Drug) $125.00
  • Impella (Device) $106.47
  • Kerendia (Drug) $104.38
  • ELIQUIS (Drug) $75.69
  • LifeVest (Device) $48.48
  • VYNDAQEL (Drug) $36.90
  • VERQUVO (Drug) $34.41
  • XARELTO (Drug) $34.40
  • LEQVIO (Drug) $31.61
  • DIAMONDBACK CORONARY (Device) $22.99
  • PRALUENT (Biological) $16.06
  • JARDIANCE (Drug) $14.66

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Student in an Organized Health Care Education/Training Program Doctors in Utica